Prediction of subclinical perhexiline neuropathy in a patient with inborn error of debrisoquine hydroxylation.
D000787:Angina Pectoris / Q000188:drug therapy; D003647:Debrisoquin / Q000378:metabolism*; D004576:Electromyography; D006801:Humans; D006900:Hydroxylation; D007546:Isoquinolines / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010480:Perhexiline / Q000009:adverse effects* / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D010641:Phenotype; D010880:Piperidines / Q000009:adverse effects*; D011110:Polymorphism, Genetic
D007546:Isoquinolines; D010880:Piperidines; D010480:Perhexiline; D003647:Debrisoquin